IL121748A0 - Vanadium complexes of hydroxamates and pharmaceutical compositions comprising them - Google Patents
Vanadium complexes of hydroxamates and pharmaceutical compositions comprising themInfo
- Publication number
- IL121748A0 IL121748A0 IL12174897A IL12174897A IL121748A0 IL 121748 A0 IL121748 A0 IL 121748A0 IL 12174897 A IL12174897 A IL 12174897A IL 12174897 A IL12174897 A IL 12174897A IL 121748 A0 IL121748 A0 IL 121748A0
- Authority
- IL
- Israel
- Prior art keywords
- hydroxamates
- pharmaceutical compositions
- vanadium complexes
- vanadium
- complexes
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000003681 vanadium Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C9/00—Aliphatic saturated hydrocarbons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/005—Compounds of elements of Group 5 of the Periodic System without metal-carbon linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
- A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL12174897A IL121748A0 (en) | 1997-09-11 | 1997-09-11 | Vanadium complexes of hydroxamates and pharmaceutical compositions comprising them |
EP98942991A EP1023251A1 (en) | 1997-09-11 | 1998-09-10 | Vanadium complexes of monohydroxamates and pharmaceutical compositions comprising them |
PCT/IL1998/000441 WO1999012875A1 (en) | 1997-09-11 | 1998-09-10 | Vanadium complexes of monohydroxamates and pharmaceutical compositions comprising them |
KR1020007002553A KR20010023870A (en) | 1997-09-11 | 1998-09-10 | Vanadium complexes of monohydroxamates and pharmaceutical compositions comprising them |
JP2000510690A JP2001515874A (en) | 1997-09-11 | 1998-09-10 | Vanadium complex of monohydroxamic acid salt and pharmaceutical composition comprising the complex |
AU90939/98A AU748278B2 (en) | 1997-09-11 | 1998-09-10 | Vanadium complexes of monohydroxamates and pharmaceutical compositions comprising them |
IL13495198A IL134951A0 (en) | 1997-09-11 | 1998-09-10 | Vanadium complexes of hydroxamates and pharmaceutical compositions comprising them |
BR9812640-7A BR9812640A (en) | 1997-09-11 | 1998-09-10 | Vanadium monohydroxamate complexes and pharmaceutical compositions comprising the same |
CA002303444A CA2303444A1 (en) | 1997-09-11 | 1998-09-10 | Vanadium complexes of monohydroxamates and pharmaceutical compositions comprising them |
CN98810940A CN1278785A (en) | 1997-09-11 | 1998-09-10 | Vanadium complexes of monohydroxamates and pharmaceutical compositions comprising them |
US09/508,411 US6414029B1 (en) | 1997-09-11 | 1998-09-10 | Vanadium complexes of monohydroxamates and pharmaceutical compositions comprising them |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL12174897A IL121748A0 (en) | 1997-09-11 | 1997-09-11 | Vanadium complexes of hydroxamates and pharmaceutical compositions comprising them |
Publications (1)
Publication Number | Publication Date |
---|---|
IL121748A0 true IL121748A0 (en) | 1998-02-22 |
Family
ID=11070622
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL12174897A IL121748A0 (en) | 1997-09-11 | 1997-09-11 | Vanadium complexes of hydroxamates and pharmaceutical compositions comprising them |
Country Status (10)
Country | Link |
---|---|
US (1) | US6414029B1 (en) |
EP (1) | EP1023251A1 (en) |
JP (1) | JP2001515874A (en) |
KR (1) | KR20010023870A (en) |
CN (1) | CN1278785A (en) |
AU (1) | AU748278B2 (en) |
BR (1) | BR9812640A (en) |
CA (1) | CA2303444A1 (en) |
IL (1) | IL121748A0 (en) |
WO (1) | WO1999012875A1 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002036066A2 (en) * | 2000-11-01 | 2002-05-10 | Yeda Research And Development Co. Ltd. | Pharmaceutical compositions comprising organic vanadium complexes for treatment of ischemia |
WO2007043606A1 (en) * | 2005-10-12 | 2007-04-19 | Genolac Bl Corporation | Antidiabetic agent comprising anionic polyamino acid-metal complex |
WO2009032591A1 (en) * | 2007-08-28 | 2009-03-12 | Akesis Pharmaceuticals Inc. | Food effect in treatment of diabetes with vanadium salts |
CN101953846B (en) * | 2010-06-24 | 2011-12-28 | 攀枝花兴辰钒钛有限公司 | Application of medicinal composition to preparing medicament for treating diabetes |
CN101972273B (en) * | 2010-10-29 | 2011-12-21 | 攀枝花兴辰钒钛有限公司 | Application of medicine in preparing medicines for treating diabetes mellitus |
CN102134738B (en) * | 2010-12-24 | 2012-11-28 | 华东师范大学 | Preparation method of oxalic acid hydroxylamine vanadium coordination compound crystalloid with bioactivity |
AU2012226703A1 (en) * | 2011-03-07 | 2013-10-17 | Cfm Pharma Holding Bv | Use of vanadium compounds for maintaining normaglycemia in a mammal |
US20140018340A1 (en) | 2011-03-25 | 2014-01-16 | Mihir K. Chaudhuri | Insulin Mimetic Active Comprising Oxodiperoxo Vanadates and a Pharmaceutical Composition Obtained Thereof |
PL231079B1 (en) | 2012-11-07 | 2019-01-31 | Univ Jagiellonski | Vanadium complexes with hydrazide-hydrazones, process for their preparation, pharmaceutical formulations and their use |
MX2020003488A (en) | 2015-02-02 | 2022-05-24 | Forma Therapeutics Inc | 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as hdac inhibitors. |
AR103598A1 (en) | 2015-02-02 | 2017-05-24 | Forma Therapeutics Inc | BICYCLIC ACIDS [4,6,0] HYDROXAMICS AS HDAC INHIBITORS |
EP3472131B1 (en) | 2016-06-17 | 2020-02-19 | Forma Therapeutics, Inc. | 2-spiro-5- and 6-hydroxamic acid indanes as hdac inhibitors |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2619382B1 (en) * | 1987-08-11 | 1990-05-04 | Lazaro Rene | ORGANO-MINERAL VANADYL COMPOUND, PROCESS FOR OBTAINING SUCH A COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING THIS ORGANO-MINERAL COMPOUND |
IL99666A (en) * | 1991-10-07 | 1996-09-12 | Yeda Res & Dev | Vanadyl complexes of hydroxamate chelators and pharmaceutical compositions comprising them |
US5338758A (en) * | 1992-04-03 | 1994-08-16 | Schering Corporation | Bicyclic diterpene PAF antagonist compounds |
US5804601A (en) * | 1995-04-10 | 1998-09-08 | Takeda Chemical Industries, Ltd. | Aromatic hydroxamic acid compounds, their production and use |
-
1997
- 1997-09-11 IL IL12174897A patent/IL121748A0/en unknown
-
1998
- 1998-09-10 US US09/508,411 patent/US6414029B1/en not_active Expired - Fee Related
- 1998-09-10 CN CN98810940A patent/CN1278785A/en active Pending
- 1998-09-10 CA CA002303444A patent/CA2303444A1/en not_active Abandoned
- 1998-09-10 EP EP98942991A patent/EP1023251A1/en not_active Withdrawn
- 1998-09-10 KR KR1020007002553A patent/KR20010023870A/en not_active Application Discontinuation
- 1998-09-10 WO PCT/IL1998/000441 patent/WO1999012875A1/en not_active Application Discontinuation
- 1998-09-10 JP JP2000510690A patent/JP2001515874A/en active Pending
- 1998-09-10 AU AU90939/98A patent/AU748278B2/en not_active Ceased
- 1998-09-10 BR BR9812640-7A patent/BR9812640A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN1278785A (en) | 2001-01-03 |
CA2303444A1 (en) | 1999-03-18 |
BR9812640A (en) | 2000-08-22 |
JP2001515874A (en) | 2001-09-25 |
WO1999012875A1 (en) | 1999-03-18 |
AU9093998A (en) | 1999-03-29 |
US6414029B1 (en) | 2002-07-02 |
EP1023251A1 (en) | 2000-08-02 |
AU748278B2 (en) | 2002-05-30 |
KR20010023870A (en) | 2001-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUS1200028I1 (en) | 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin derivatives and pharmaceutical compositions containing them | |
IL114622A0 (en) | Heteroaryl-oxazolidinones and pharmaceutical compositions containing them | |
PT1213020E (en) | Compounds and pharmaceutical compositions having appetite suppressant activity | |
HUP0004318A3 (en) | Pharmaceutical composition comprising atorvastatin and an antihypertensive agent | |
EP0950665A4 (en) | Modified physiologically active proteins and medicinal compositions containing the same | |
HUP0100178A3 (en) | Tetrahydro-naphtiridinyl-imidazolydinyl-carboxylic acid derivatives and pharmaceutical compositions thereof | |
HUP0001309A3 (en) | 1-phenyl-4-benzylpiperazines and pharmaceutical compositions containing them | |
IL117727A0 (en) | Synergistic combinations having anti-hiv activity and pharmaceutical compositions containing them | |
HUP9701299A3 (en) | Insuline derivatives of enhanced zinc-binding activity, complexes and pharmaceutical compositions comprising thereof and their proinsulines | |
HUP0100149A3 (en) | Antipicornaviral peptide derivatives pharmaceutical compositions comprising thereof and their use | |
AU5613999A (en) | Pharmaceutical compositions of vanadium biguanide complexes and their use | |
HUP9800147A3 (en) | Isoxasol-and crotonoil-amide derivatives and pharmaceutical and diagnostical compositions containing them | |
LT99141A (en) | Pharmaceutical compositions of tizoxanide and nitazoxanide | |
IL121748A0 (en) | Vanadium complexes of hydroxamates and pharmaceutical compositions comprising them | |
ZA967800B (en) | Heteroaryllsubstituted acryloylguanidine derivatives and pharmaceutical compositions comprising them | |
HUP0100085A3 (en) | Biphenylamidine derivatives and pharmaceutical compositions containing them | |
HUP0101701A3 (en) | Substituted betha-alanines and pharmaceutical compositions comprising them | |
HUP0002331A3 (en) | 20-aralkyl-5alpha-pregnane derivatives and pharmaceutical compositions thereof | |
IL120669A0 (en) | Benzylamine derivatives and pharmaceutical compositions containing them | |
IL123040A0 (en) | Manganese complexes pharmaceutical compositions containg them and their use | |
IL126734A0 (en) | Cosmetic and/or pharmaceutical and/or dermatological compositions | |
HUP0000460A3 (en) | Imidazopyridazines and pharmaceutical compositions thereof | |
IL155799A0 (en) | Pharmaceutical compositions of tizoxanide and nitazoxanide | |
GB9501286D0 (en) | Pharmaceutical compositions and preparations thereof | |
HUP9601526A3 (en) | Peptidyl-arginin-aldehyde derivatives of anticoagulant activity and pharmaceutical compositions containing them |